Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02491515Unknown

Effects of Denosumab Therapy for Japanese

Role: lead

NCT02220322Unknown

Age-related Cognitive Change of Femur

Role: lead

NCT01990365Unknown

The Influence of Vertebral Mobility on Low Back Pain in Patients With Acute Osteoporotic Vertebral Fractures

Role: lead

NCT01969279Unknown

Radiographic Influences of Bisphosphonate Treatment on Femur

Role: lead

NCT01956461Unknown

Effects of Teriparatide Therapy for Japanese

Role: lead

NCT02166437Unknown

Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese

Role: lead

All 6 trials loaded